logo-loader

Pharma & Biotech

Add to MyProactive
Biome Australia expands global footprint, targets strong growth in clinically proven Probiotics
on 27/3/25
Candel Therapeutics shares positive survival data for investigational immunotherapy in NSCLC
on 27/3/25
Candel Therapeutics Inc - Candel Therapeutics reports positive survival data for CAN-2409 in advanced lung cancer trial
on 26/3/25
Tiziana Life Sciences Ltd -
on 25/3/25
Zero Candida begins trading on OTCQB, advances AI-driven women’s health solutions
on 24/3/25
Protalix Biotherapeutics Inc - Protalix Biotherapeutics chairman discusses breakthrough in gout treatment, drug pipeline - ICYMI
on 21/3/25
Healthcare investment strategies reshaped by inflation, interest rates and M&A in 2025
on 21/3/25
Candel Therapeutics Inc - Candel Therapeutics partners with IDEA Pharma on commercialization of lead asset CAN-2409
on 20/3/25
Protalix BioTherapeutics pipeline eyes gout treatment as financial strength fuels future growth
on 18/3/25
Candel Therapeutics Inc -
on 18/3/25
atai Life Sciences - atai Life Sciences reports progress in clinical trials as it strengthens financial position   
on 17/3/25
Immunic Inc -
on 14/3/25
Tonix Pharmaceuticals secures MCDC grant to advance next-gen Mpox & Smallpox vaccine development
on 14/3/25
Candel Therapeutics Inc -
on 13/3/25
Zero Candida Ltd - Zero Candida starts trading on the OTCQB Venture Market
on 12/3/25
Immunic Therapeutics advances MS Drug , Phase 2 CALLIPER trial readout in April
on 11/3/25
atai Life Sciences - atai Life Sciences doses first patient in Phase 2 treatment-resistant depression trial
on 11/3/25
OKYO Pharma Ltd - OKYO Pharma seeks FDA Fast Track designation for neuropathic corneal pain treatment
on 10/3/25
Medicus Pharma - Medicus Pharma CEO discusses latest skin cancer trial results - ICYMI
on 8/3/25
Lisata Therapeutics Inc - Lisata Therapeutics CEO discusses AI drug discovery collaboration
on 8/3/25
OSZAR »